Citadel Advisors
CORZ icon

Citadel Advisors’s Core Scientific CORZ Stock Holding History

Citadel Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103M Sell
4,041,333
-2,093,022
-34% -$49.3M 0.01% 953
2026
Q1 		$91.8M Sell
6,134,355
-4,196,411
-41% -$71.6M 0.01% 875
2025
Q4 		$150M Buy
10,330,766
+5,312,905
+106% +$92.6M 0.02% 628
2025
Q3 		$90M Buy
5,017,861
+3,573,942
+248% +$52.4M 0.01% 919
2025
Q2 		$24.6M Buy
1,443,919
+773,814
+115% +$7.74M ﹤0.01% 1910
2025
Q1 		$4.85M Sell
670,105
-799,273
-54% -$9.1M ﹤0.01% 3923
2024
Q4 		$20.6M Buy
1,469,378
+282,651
+24% +$4.18M ﹤0.01% 2133
2024
Q3 		$14.1M Buy
1,186,727
+1,167,983
+6,231% +$12.1M ﹤0.01% 2460
2024
Q2 		$174K Sell
18,744
-5,257,076
-100% -$26.9M ﹤0.01% 10130
2024
Q1 		$18.7M Buy
+5,275,820
New +$18.3M ﹤0.01% 2143

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Citadel Advisors's CORZ Position: Q2 2026 in Review

Citadel Advisors reduced its Core Scientific (CORZ) stake by 34% in Q2 2026, selling an estimated $49.3M and leaving 4,041,333 shares worth $103M. The position accounts for 0.01% of the portfolio, ranked #953.

Citadel Advisors first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $150M in Q4 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Citadel Advisors held 4,041,333 shares of Core Scientific worth $103M as of Q2 2026.
  • Citadel Advisors sold 2,093,022 Core Scientific shares in Q2 2026, an estimated $49.3M.
  • Core Scientific made up 0.01% of Citadel Advisors's portfolio in Q2 2026, its #953 holding.
  • Citadel Advisors first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • Citadel Advisors's Core Scientific position peaked at $150M in Q4 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.